Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00178932
NCT00178932
Completed
Not Applicable

Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors

Northwestern University1 site in 1 country37 target enrollmentNovember 1998
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSchizophreniaSchizoaffective DisorderBipolar DisorderMajor Depression

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
Northwestern University
Enrollment
37
Locations
1
Primary Endpoint
We plan to compare the polymorphisms across schizophrenic patients and adults who do not have a diagnosed major mental illness. .
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The goals of this study are to replicate previous findings of genetic predictors of response to clozapine and other antipsychotic drugs.

Registry
clinicaltrials.gov
Start Date
November 1998
End Date
May 16, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Patients with the diagnoses of schizophrenia or schizoaffective disorder, and bipolar disorder or major depression with psychotic features, or volunteers with no history of a psychotic disorder.

Exclusion Criteria

  • •Patients with DSM-IV diagnoses other than schizophrenia or schizoaffective disorder, and bipolar disorder or major depression with psychotic features.

Outcomes

Primary Outcomes

We plan to compare the polymorphisms across schizophrenic patients and adults who do not have a diagnosed major mental illness. .

Time Frame: single visit

Secondary Outcomes

  • We will also evaluate relationships between the polymorphism and past and current mental health among the non-diagnosed sample(single visit)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Program for the Introduction Into Clinical Practice of the Principles of Personalized and Preventive Medicine Based on the Isolation of Gene Polymorphism in Schizophrenia in People of the Kazakh Ethnic GroupSchizophrenia
NCT05090644Asfendiyarov Kazakh National Medical University700
Completed
Not Applicable
A Study of Strategies to Improve Schizophrenia TreatmentSchizophreniaSchizoaffective Disorder
NCT00156637US Department of Veterans Affairs106
Completed
Not Applicable
Improving Accessibility and Personalization of CR for SchizophreniaSchizophreniaSchizoaffective Disorder
NCT03576976New York State Psychiatric Institute67
Completed
Not Applicable
Cognitive Remediation and Sheltered Employment in SchizophreniaChronic Schizophrenia
NCT01891929Hôpital le Vinatier79
Unknown
Not Applicable
Novel Candidate Genes for Treatment Response to Antipsychotics in SchizophreniaSchizophrenia
NCT02205437Fundación Marques de Valdecilla200